Neuroimmune hypothesis of atherosclerosis

Biomedical Reviews

Volumn 10, Issue 1, 1999, Pages 37-44

  Chaldakov, George N ^a   Fiore, Marco ^b   Stanknlov, Ivan S ^a   Triaca, Viviana ^b   Ghenev, Peter I ^a   Aloe, Luigi ^b  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011055960     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v10.6     Document Type: Article

References (123)

1. Levi-Montalcini R. The Saga of the Nerve Growth Factor. Preliminary Studies, Discovery, Further Development. World Scientific, Singapore, 1997.
2. Kahler CM, Schratzberger P. Wiedermann CJ. Response of vascular smooth muscle cells to the neuropeptide secre-toneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol 1997; 17:2029-2035.
3. Nagtegaal ID, Lakke EAJF, Marani E. Trophic and tropic factors in the development of the central nervous system. Arch Physiol Biochem 1998; 106: 161-202.
4. Lai KO, Fu WY, Ip FCF, Ip NY. Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 1998;11:64-76.
5. Orestein NS. Dvorak HF. Blanchard MH, Young M. Nerve growth factor: a protease that can activate plasminogen. Proc Natl Acad Sci USA 1978; 75: 5497-5500.
6. Hayden MR, Reidy M. Many roads lead to atheroma. Nat Med 1995; 1:22-23.
7. Grainger DJ, Kemp PR, Metcalfe J, Liu AC, Lawn RM, Williams NR et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1995; 1:74-79.
8. Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with nerve growth factor. Brain Res 1977;133:358-366.
9. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91:3739-3743.
10. Burgi B, Otten UH, Ochensberger B, Rihs S, Heese K, Ehrhard PB et al. B asophil priming by neurotrophic factors. Activation through the trk receptor. J Immunol 1996; 157: 5582-5588.
11. Lambiase A, Bracci-Laudiero L, Bonini S, Bonini S, Starace G, D'Elios MM et al. Human CD4+Tcell clones produce and release nerve growth factor and express high-affinity nerve growth factorreceptors. J Allergy Clin Immunol 1997; 100: 408414.
12. Marcinkiewicz M, Marcinkiewicz J, Chen A, Leclaire F, Chretien M, Richardson P. Nerve growth factor and proprotein convertases furin and PC7 in transected sciatic nerves and in nerve segments cultured in conditioned media: their presence in Schwann cells, macrophages, and smooth muscle cells. J Comp Neurol 1999;403:471-485.
13. Hannestad J, Levanti MB, Vega JA. Distribution of neurotrophin receptors in human palatine tonsils: an immu-nohistochemical study. J Neuroimmunol 1995; 58: 131-137.
14. Kannan Y, Usami K, Okada M, Shimizu S, Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biopliys Res Commun 1992; 186: 1050-1056.
15. Labouyric E, Dubus P, Groppi A, Mahon FX, Ferrer J, Pairrens M et al. Expression of neurotrophins and their receptors in human bonemarrow. Am J Pathol 1999; 154:405-415. (Pubitemid 29094091)
16. Leventhal C, Rafii S, Rafii D, Shahar A, Goldman SA. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci 1999; 13:450-464.
17. Cowcn T, Gavazzi I. Plastisity in adult and ageing sympathetic neurons. Prog Neurobiol 1998; 54:249-288.
18. Hattori A, Iwasaki S, Murase K, Tsujimoto M, Sato M, Hayashi K et al. Tumor necrosis factor is markedly sy nergis-ticwilhintcrlcukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994;340:177-180.
19. Yamamoto H, Gurncy ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990; 10:3469-3478.
20. Brusov OS, Zlobina GP, Nikolaeva EA, Ulas V, Faktor MI, Pavlova OA et al. The indices of the thrombocyte serotonin system and the nerve growth factor system in children with hereditary disorders of neuropsychic development. Zl Neurol Psikhiatr Im SS Korsakova 1999; 98: 27-31 (in Russian).
21. Nisoli E, Tonello C, Benarese M, Liberini P, Carruba MO. Expression of nerve growth factor in brown adipose tissue: implications for thermogenesis and obesity. Endocrinology 1996; 137:495-503.
22. Brodie C. Platelet activating factor induces nerve growth factor production by ratastrocytes. Neurosci Lett 1995; 186: 5-8.
23. Artuc M, Hermes B, Steckelings UM, Grutzkan A, Henz BM. Mast cells and their mediators in cutaneous wound healing: Active participants or innocent bystanders. Exp Dermatol 1999;8:1-16.
24. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J. Nerve growth factor modulates the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999; 162:4271-4276.
25. Marshall JS, Waserman S. Mast cells and the nerves-potential interactions in the context of chronic disease. Clin Exp Allergy 1995;25:102-110.
26. Carnahan JF, Patel DR, Miller JA. Stem cell factor is a neurotrophic factor for neural crest-derived chick sensory neurons. J Neurosci 1994; 14:1433-1440.
27. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Imnuinol Today 1994; 15: 533-53.
28. Theodorou V, Fioramonti J, Bueno L. Intergrative neuro-immunology of the digestive gut tract. Vet Res 1996; 27:427-442.
29. Otten U, Gadient RA. Neurotrophins and cytokines-intermediaries between the immune and nervous systems. Int J Dev Neurosci 1995; 13:147-151.
30. Chaldakov GN, Ghenev PI, Vachanov K, Tonchev A, Panchcva R. Nerve-mast cell-nerve growth factor link: the mast cell as yin-yang modulator in inflammation and fibrosis. Biomed Rev 1995; 4:1-6.
31. Saldanha G, Hongo J, Plant G, Acheson J, Levy I, Anand P. Decreased CGRP, but preserved Trk A immunoreactivity in nerve fibers in inflamed human superficial temporal arteritis. J Neurol Neurosurg Psychiatry 1999;66:390-392.
32. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, Pang X, Theoharides TC. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res 1999; 849:1-15.
33. Schreiber RC, Shadiack AM, Bennett TA, Sedwick CE, Zigmond RE. Changes in the macrophage population of the rat superior cervical ganglion after postganglionic nerve injury. J Neurobiol 1995; 27:141-153.
34. Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zoo/1949; 111:457-501.
35. Ross R. Mechanisms of disease: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
36. Chaldakov GN, Vankov VN. Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to the Golgi complex and microtubular cytoskeleton. Atherosclerosis 1986; 61:175-192.
37. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15:551-561.
38. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
39. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 1997; 11: 1199-1207.
40. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095-4103.
41. Sloop GD. Insights into the relationship of fatty streaks to raised atherosclerotic lesions provided by the hemo-rheologic-hemodynamic theory of atherogenesis. Med Hypotheses 1998; 51: 385-388.
42. Van der Loo B, Martin JF. The adventitia, endothelium and atherosclerosis. Int J Microcirc Clin Exp 1997; 17:280-288.
43. Kozai T, Shimokawa H, Yamawaki T, Fukumoto Y, Kadokami T, Kuwata K et al. Platelet activating factor causes hyper-constriction at the inflammatory coronary lesions in pigs in vitro. Coron Artery Dis 1997; 8: 423-432.
44. Arbustini E, Roberts WC. Morphological observations in the epicardial coronary arteries and their surroundings late aftercardiac transplantation. Am J Cardiol 1996; 78: 814-820.
45. Chaldakov GN, Properzi F, Ghenev PI, Fiore M, Stankulov IS, Aloe L. Artery-associated adipose tissue and atherosclerosis: correlative analysis of NGF and mast cells in human coronary atherosclerosis [abstract]. Atherosclerosis 1999; 146(Suppl l):S33.
46. Bono F, Lamarche I, Herbert JM. NGF exhibits a proapo-ptotic activity for human vascular smooth muscle that is inhibited by TGF-β1. FEBS Lett 1997;416:243-246.
47. Creedon DJ, Tuttle JB. Synergistic increase in nerve growth factor secretion by cultured vascular smooth muscle cells treated'with injury-related growth factors. J Neurosci Res 1997;47:277-286.
48. Sherer TB. Spitsbergen JM. Steers WD, Tuttle JB. Thrombin regulates nerve growth factor secretion from vascular, but not bladder smooth muscle cells. Cell Tissue Res 1997;289: 155-161.
49. Neomoto K, Fukamashi K, Nemoto F, Miyata S, Hamada M, Nakamura Y et al. Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1998;245:284-288.
50. Kraemer R, Nguyen H, March KL, Hempstad B. NGF activates similar inracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responses. Arterioscler Thromb Vasc Biol 1999; 19: 1041-1050.
51. Scarisbrick IA, Jones EG, Isackson PJ. Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre-and postnatal rat. J Neurosci 1993; 13:875-893.
52. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D et al. Neurotrophin and neurotropin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995; 147:309-324.
53. Miyamoto T, Sasaguri Y, Sasaguri T, Azakami S, Yasukawa H, Kato S et al. Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 1997; 129:207-213.
54. Patella V, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998;97:971-978.
55. Qu Z, Huang X, Ahmadi P, Stenberg P, Liebler JM, Le AC et al. Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor-β, tumor necrosis factor-α, and stem cell factor. Int Arch Allergy Immunol 1998; 115:47-54.
56. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogcl H, Welker P et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998; 9: 875-884.
57. Rush RA, Mayo R, Zettler C. The regulation of nerve growth factor synthesis and delivery to peripheral neurons. Phrarmac Ther 1995;65:93-123.
58. Bell C. Neurotrophic abnormalities and development of high blood pressure in genetically hypertensive rats. Biomed Rev 1996; 6:43-55.
59. Falcini F, Cerinic MM, Ermini M, Generini S, Lomardi A, Pignone A et al. Nerve growth factor circulating levels arc increased in Kawasaki disease: correlation with diseases activity and reduced angiotensin converting enzyme level. J Rheumatol 1996;23:1798-1802.
60. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145:33-43.
61. Kaartinen M, Van der Wal AC, Van der Loos CM, Pick JJ, Koch KT, Becker AE et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol 1998; 32: 606-612.
62. Lee WH, Lee Y, Kim JR, Chu JA, Lee SY, Jung JO et al. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients. Exp Mol Med 1999; 31:159-164.
63. Pasceri V, Yeh ETH. A tale of two diseases. Atherosclerosis and rheumatoid arthritis. Circulation 1999; 100:2124-2126.
64. Chaldakov GN, Deyl Z, Va'nkov VN. Colchicine: possible new application of its antifibrotic (antisecretory) action. Physiol Bohemoslov 1987; 36:1-7.
65. Markowitz SD. Atherosclerosis, just another cancer? J Clin Invest 1997; 100:2143-2145.
66. Tuvcri MA, Passiu G, Mathieu A, Aloe A. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol 1993; 11:319-322.
67. Simone MD, DeSantis S, Vigneti E, Papa G, Amadori S, Aloe L. Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 1999; 17:1-10. (Pubitemid 29410396)
68. Aloe L, Micera A. Nerve growth factor: basic findings and clinical trials. Biomed Rev 1999; 10:3-14.
69. Donovan MJ, Hahn R, Tessarollo L, Hempstead BL. Identification of an essential nonneuronal function of NT-3 in mammalian cardiac devclopment. Nat Genet 1996; 14:210-213.
70. Chaldakov GN, Properzi F, Ghenev PI, Fiore M, Stankulov IS, Aloe L. Correlative analysis of NGF, p75NGF receptor and mast cells in human coronary atherosclerosis. An artery-to-adipose tissue study, [abstract]. Biomed Rev 1998; 9: VIII.
71. Mukherjec SP. Mukherjee C. Similar activities of nerve growth factor and its homologue proinsulin in intracellular hydrogen peroxide production and metabolism in adipocytes. Transmembrane signalling relative to insulin-mimicking effects. Biochem Pharmacol 1982; 31: 3163-3172.
72. Ng TB, Wong CM. Epidermal and nerve growth factors manifest antilipolytic and Iipogcnic activities in isolated rat adipocytes. Comp Biochem Physiol (B) 1985; 81:687-689.
73. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C et al. Brain-derived neurotrophic factor reduces blood glucose level in obesediabetic mice but not in normal mice. Biochem Biophys Res Comimin 1997; 238:633-637.
74. Rosenbaum T, Vidaltamayo R, Sanchez-Soto MC, Zentella A, Hiriart M. Pancreatic β cells synthesize and secrete nerve growth factor. Proc Natl Acad Sci USA 1998; 95:7784-7788.
75. Blottncr D, Wolf N, Lachmund A, Flanders KC, Unsicker K. TGF-β rescuses traget-depri ved preganglionic sympathetic neurons in the spinal cord. Eur J Neurosci 1996; 8:202-210.
76. Maina F, Hilton MC, Anders R, Wyatt S, Klein R, Davies A. Multiple roles for hepatocytc growth factor in sympathetic neuron development. Neuron 1998;20:835-846.
77. Sondcll M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999;19:5731-5740.
78. Schneider C, Wicht H, Enderich J, Wegner M, Rohrer H. Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 1999; 24: 861-870.
79. Eccleston PA, Funa K, Heldin CH. Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia. Dev Biol 1993; 155:459-470.
80. Wang Y. Kovancn PT. Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture. Circ Res 1999; 84: 74-83.
81. Abe T, Morgan DA, Gutterman DD. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997; 95: 213-220.
82. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A et al. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998; 187: 297-306.
83. Miyazawa N. Watanabe S, Matsuda A, Kondo K. Hashimoto H, Umemura K et al. Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur J Pharmacol 1998; 362:53-59.
84. Kacem K. Bonvento G, Seylaz J. Effect of sympathectomy on the phenotype of smooth muscle cells of middle cerebral and ear arteries of hyperlipidemic rabbits. Histochem J 1997; 29:279-286.
85. Bu G, Sun Y, Schwartz AL, Holtzman DM. Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein-related protein. J Biol Client 1998;273: 13359-13365.
86. Moran CS, Campbell JH, Campbell GR. Human leukemia inhibitory factor upregulates LDL receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbit. Arterioscler Thromb Vasc Biol 1997; 17:1267-1273.
87. Moran CS, Campbell JH, Simmons DL, Campbell GR. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis. Arterioscler Thromb 1994; 14:1356-1363.
88. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzcr JL, Sargiacomo M et al. Expression of caviolin-1 and-2 in differentiating PC 12 cells and dorsal root ganglion neurons: cavcolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 1998;95:10257-10262.
89. Nonogaki K, Moser AH, Shigenaga J, Feingold KR, Grunfeld C. Beta-nerve growth factor as a mediator of the acute phase response in vivo. Biochem Biophys Res Commun 1996;219: 956-961.
90. Hermann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL. Mediation of NGF-stimulatedextracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trk A. Mol Biol Cell 1993; 4:1205-1216.
91. Muir D. Metalloproteinase-dependent ncurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 1994;210:243-252.
92. Mills EM, Takeda K. Yu ZX, Ferrans V. Katagiri Y, Jiang H et al. Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC 12 cells. J Biol Client 1998;273:22165-22168. (Pubitemid 28399767)
93. Neuman H, Misgeld T, Matsumuro K, Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibi-lity of microglia: involvement of the p75 neurotrophin receptor. Neurobiology 1998;95:5779-5784.
94. Ueyama T, Hano T, Hamada M, Nishio I, Masuyama Y. New role of nerve growth factor - an inhibitory neuromodulator of adrenergic transmission. Brain Res 1991; 559:293-296.
95. Kovanen PT. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation. Curr Opin Lipidol 1996;7:281-286.
96. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: result at autopsy. Circulation 1985;71:709-716.
97. Baroldi G, Silver MD, Mariani F, Giuliano G. Correlation of morphological variables in the coronary atherosclerotic plaque with clinical patterns of ischemic heart disease. Am J Cardiovasc Pathol 1988; 2: 159-172.
98. Ghenev PI, Chaldakov GN. Neural-immune links in adventitial remodeling in human coronary atherosclerosis. Circulation 1997;96:2083-2084.
99. Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Schwartz SM, Rosenfeld ME. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb Vasc Biol 1997; 17:3593-3601.
100. Scott TM, Honey AC, Martin JF, Booth RF. Perivascular innervation is lost in experimental atherosclerosis. Car-ďtoscience 1992;3:145-153.
101. Milner P, Crowe R, Loesch A, Anglin S, Burnstock G, McEwan JR. Neurocompenstory responses to balloon-catheter-induced injury of the ratcarotid artery. J Vasc Res 1997;34:31-40.
102. Liu DT, Reid MT. Bridges DCMcL. Rush RA. Dencrvation, but not decentralization, reduces nerve growth factor content of the mesenteric artery. J Neurochem 1996; 66: 2295-2209.
103. Rader DJ, Fitzgerald GA. State of the art: atherosclerosis in a limited edition. Nat Med 1998;4:899-900.
104. Fullerton SM, Strittmatter WJ, Mathew WD. Peripheral sensory nerve defects in apolipoprotein E knockout mice. Exp Neurol 1998;153:156-163.
105. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 1992; 69:737-749.
106. Bernabei R, Landi F, Bonini S, Onder G, Lambiase A, Pola R et al. Effect of topical application of nerve growth factor on pressure ulcers. Lancet 1999; 354:307.
107. Lambiase A, Rama, P, Aloe L, Bonini S. Management of neurotrophic keratopathy. Curr Opin Ophtalmol 1999; 10: 270-277.
108. Amico-Roxas M, Caruso A, Leone MG, Scifo R, Vanella A, Scapagnini U. Nerve growth factor inhibits some acute experimental inflammations. Arch Int Pharmacodyn Tlier 1989;299:269-285.
109. Kim SJ, Park K, Rudkin BB, Dey BR, Sporn MB, Roberts AB. Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element inPC12cells. J Biol Chem 1994;269:3739-3744.
110. Gollapudi L, Oblinger MM, Estrogen and NGF synergis-tically protect terminally differentiated, estrogen receptor-α-transfected PC 12 cells from apoptosis. J Neurosci Res 1999; 56: 471-478.
111. Conover JC, Yancopoulos GD. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci 1997; 8: 13-27.
112. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M et al. Role of adipocy tokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999;38:202-206.
113. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
114. Gigolini M, Tonoli M, Borgato L, Frigotto L, Manzato F, Zemiman S et al. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role of tumor necrosis factor-α. Atherosclerosis 1999; 143:81-90.
115. Engeli S, Gorzelniak K, Kreutz R, Runkcl N, Distler A, Shaarma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17:555-560.
116. Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol Med 1997; 3:37-48.
117. Ishii T, Asuwa N, Masuda S, Ishikawa Y. The effects of a myocardial bridge on coronary atherosclerosis and ischemia. J Pathol 1998; 185:4-9.
118. Ferrer P, Valentine M, Jenkins-West T, Gale T, Gu K, Havens C et al. Periadventitial changes in the balloon injured rat carotid artery, [abstract]. FASEB J 1996; 10: A618.
119. Dettman RW, Denetclaw Jr W, Ordahl CP, Bristow J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998; 193:169-181.
120. Ichinose Y, Asoh H, Yano T, Yokoyama H, Inoue T, Tayama K et al. Use of a pericardial fat pad flap for preventing bronchopleural fistula: an experimental study focusing on the angiogenesis and cytokine production of the fat pad. Surg Today 1995; 25:811-815.
121. Galli SJ, Wershil BK. The two faccs of the mastcell. Nature 1996;381:21-22.
122. Furukawa S, Nitta A, Furukawa Y. Stimulation of neurotrophin synthesis by 4-methylcatechol: a promising approach for neuroprotection. Biomed Rev 1999; 10:45-54.
123. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-1162.